FBInvestor
Stocks / Silence Therapeutics PLC
Institutional Ownership

Silence Therapeutics PLC

CUSIP 82686Q101ADSSLNQ1 2026

Earnings

Quarterly EPS and revenue are sourced from SEC XBRL financial statements. We ingest the top issuers first; this fills in as coverage expands (or this security isn't mapped to an SEC filer yet).

Coming soon